CaliPharms Inc (KGET)

[zapit81]

CaliPharms Welcomes its New CEO - Eric Watson -- CEO has Directed Plans for Branding CaliPharms in the Cannabis Sector

Sep 20, 2017

OTC Disclosure & News Service

Riverside, CA -

CaliPharms, Inc. (OTCPink:KGET), a Company operating in the California Medicinal Cannabis industry and publicly trading under the OTC Markets symbol as "KGET", is pleased to introduce its new CEO - Eric Watson.
Eric Watson has been named the CEO of CaliPharms. Watson has been involved in the Cannabis sector for over 25 years. In 2009 he co-founded Green Door Hydro & Solar Electric in Los Angeles, which quickly grew to become one of the top three indoor gardening supply depots in California, serving as a hub for the market at large in Los Angeles. Watson is also the co-founder of entertainment company Protozoa Pictures, which has produced several major motion pictures since 1997, including BLACK SWAN and THE WRESTLER. Blending his intimate understanding of the Cannabis sector with his business acumen, CaliPharms CEO Watson plans to guide the company into a strong, leading industry position.

Watson continued, We are at the precipice of a once in a lifetime opportunity, as a $50 Billion industry moves into the mainstream. With the rapid expansion of retail opportunities as the tide of prohibition wanes, the customer base continues to grow exponentially for consistently produced high quality Cannabis products. Branded products are the future of the industry, and we plan to immediately launch a full line of clean CBD and THC products for the mainstream consumer with the goal of establishing our brand as the market leader CaliPharms will be what customers reach for when it comes time to purchase.

CaliPharms subsidiary Country Junction Farms (CJF) has elected to unwind the acquisition agreement between CJF and CaliPharms. Under the agreement provisions there is a clause that CJF may unwind the transaction for any reason, provided CJF has not sold any of the stock issued to CJF as consideration for the transaction. CJF did not sell or convert KGET stock, or received any cash consideration for the contracted acquisition, so the unwinding provision is considered valid by CaliPharms. CaliPharms wished great success to CJF in the future.


Please see our company videos:

Company Vision

Business Vision

http://www.otcmarkets.com/stock/KGET/news